A Covid-19 surge that never came and earlier improvements to labor costs pushed DaVita Inc. (NYSE: DVA) into the top end of its expectations for the fourth quarter.
Leadership for the Denver-based kidney care company said they expect higher wage demands to continue at above-normal levels this year, but below those seen in 2022.
https://www.bizjournals.com/denver/news/2023/02/23/davita-fourth-quarter-earnings.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.